167 related articles for article (PubMed ID: 1681628)
1. [Continuous enoximone infusion in patients with severe heart failure in dilated cardiomyopathy, hemodynamic, neurohumoral, chemical laboratory and clinical results].
Neuzner J; Mitrovic V; Pitschner HF; Lissmann H; Schlepper M
Z Kardiol; 1991 Jun; 80(6):397-403. PubMed ID: 1681628
[TBL] [Abstract][Full Text] [Related]
2. Low-dose enoximone therapy in pre-transplant patients: hemodynamic, echocardiographic, and neurohumoral findings.
Park JW; Heinzler R; Wirtz JH; Fieten-Rumswinkel M; Braun P; May E; Hetzer R; Heinrich KW
Z Kardiol; 1994; 83 Suppl 2():49-53. PubMed ID: 8091824
[TBL] [Abstract][Full Text] [Related]
3. [Neurohumoral and hemodynamic effects in combination therapy of enoximone and dopamine].
Mitrovic V; Neuzner J; Opper H; Thormann J; Schlepper M
Z Kardiol; 1994; 83 Suppl 2():37-48. PubMed ID: 8091823
[TBL] [Abstract][Full Text] [Related]
4. [The hemodynamic profile of amrinone and enoximone in patients with severe heart failure].
Saborowski F; Peters P; Schneider M
Z Kardiol; 1991; 80 Suppl 4():63-7. PubMed ID: 1833900
[TBL] [Abstract][Full Text] [Related]
5. [Vasodilatation and positive inotropic effect of the phosphodiesterase inhibitor enoximone].
Holubarsch C; Hasenfuss G; Thierfelder L; Heiss HW; Just H
Z Kardiol; 1991; 80 Suppl 4():35-40. PubMed ID: 1833895
[TBL] [Abstract][Full Text] [Related]
6. The influence of various degrees of cardiac failure, chronic medical treatment, and acute additional enoximone application on the parameters of the vasopressor system.
Mitrovic V; Neuzner J; Husseini H; Volz M; Schlepper M
J Cardiovasc Pharmacol; 1989; 14 Suppl 1():S40-9. PubMed ID: 2480485
[TBL] [Abstract][Full Text] [Related]
7. [Enoximone: hemodynamic effect in patients with cardiac insufficiency].
de Langenhagen B; Bouchoucha H; Scholl JM; Hennetier G; Benacerraf A; Achard F; Bock F
Arch Mal Coeur Vaiss; 1990 Sep; 83 Spec No 3():19-25. PubMed ID: 2147830
[TBL] [Abstract][Full Text] [Related]
8. Acute enoximone effect on systemic and renal hemodynamics in patients with heart failure.
Berti S; Palmieri C; Ravani M; Bonini R; Iascone MR; Clerico A; Manfredi C; Iervasi G; Ferrazzi P; Biagini A
Cardiovasc Drugs Ther; 1996 Mar; 10(1):81-7. PubMed ID: 8723174
[TBL] [Abstract][Full Text] [Related]
9. [Treatment of chronic cardiac insufficiency with intravenous bolus enoximone. Study of a pharmacokinetic-hemodynamic relation].
Gibelin P; Garraffo R; Sbirrazzuoli V; Lapalus P; Morand P
Arch Mal Coeur Vaiss; 1990 Sep; 83 Spec No 3():75-81. PubMed ID: 2147839
[TBL] [Abstract][Full Text] [Related]
10. [Comparison of the hemodynamic effect of enoximone and dopamine in patients after coronary bypass operation].
Birnbaum DE; Preuner JG; Gieseke R; Kasper-König W; Trenk D; Jähnchen E; Dieterich HA
Z Kardiol; 1991; 80 Suppl 4():47-52. PubMed ID: 1833897
[TBL] [Abstract][Full Text] [Related]
11. Hemodynamic effects of prolonged intravenous therapy with enoximone in patients with severe congestive heart failure.
Ferry DR; Kennedy GT; O'Rourke RA; Crawford MH
J Cardiovasc Pharmacol; 1988 Jan; 11(1):115-22. PubMed ID: 2450249
[TBL] [Abstract][Full Text] [Related]
12. Short-term effects of oral enoximone on hemodynamics, exercise capacity, anaerobic threshold, and arrhythmias in congestive heart failure.
Klauss V; Zwehl W; Mudra H; Huber R; Schmidt R; Scheininger M; Vogler A; Tschaidse O; Dieterich HA; Theisen K
Klin Wochenschr; 1991 Jul; 69(10):430-5. PubMed ID: 1719270
[TBL] [Abstract][Full Text] [Related]
13. Hemodynamic and neurohumoral effects of long-term prostaglandin E1 infusions in outpatients with severe congestive heart failure.
Hülsmann M; Stanek B; Frey B; Berger R; Rödler S; Siegel A; Hartter E; Schuller M; Ogris E; Pacher R
J Heart Lung Transplant; 1997 May; 16(5):556-62. PubMed ID: 9171275
[TBL] [Abstract][Full Text] [Related]
14. High-dose enoximone to evaluate reversibility of pulmonary hypertension: is there a diagnostic value of neurohormonal measurements?
Schulz O; Mitrovic V; Schönburg M; Thormann J
Am Heart J; 1999 May; 137(5):887-94. PubMed ID: 10220638
[TBL] [Abstract][Full Text] [Related]
15. [Enoximone, vasodilator and/or inotropic agent in congestive cardiac insufficiency? Hemodynamic and ventriculographic study of 20 cases].
Durrieu C; Rochoux G; Coste P; Le Goff G; Besse P
Arch Mal Coeur Vaiss; 1990 Sep; 83 Spec No 3():43-50. PubMed ID: 2147834
[TBL] [Abstract][Full Text] [Related]
16. [Enoximone as pharmacologic "bridging" to heart transplantation].
Friedel N; Teebken M; Lemme A; Schüler S; Hetzer R
Z Kardiol; 1991; 80 Suppl 4():27-33. PubMed ID: 1833894
[TBL] [Abstract][Full Text] [Related]
17. Placebo-controlled study of oral enoximone in congestive heart failure with initial and final intravenous hemodynamic evaluation.
Khalife K; Zannad F; Brunotte F; Belhadj K; Juilliere Y; Iannascoli F; Gilgenkrantz JM
Am J Cardiol; 1987 Aug; 60(5):75C-79C. PubMed ID: 2956874
[TBL] [Abstract][Full Text] [Related]
18. Cardiac energetics after intravenous enoximone in idiopathic dilated cardiomyopathy.
Heiss HW; Hasenfuss G; Holubarsch C; Meinertz T; Just H
Am J Cardiol; 1987 Aug; 60(5):53C-56C. PubMed ID: 2956869
[TBL] [Abstract][Full Text] [Related]
19. Pharmacodynamics of enoximone during intravenous infusion.
Winkle RA; Smith NA; Ruder MA; Mead RH; Lebsack C; Bekele T; Kates RE; Rubin J; Okerholm R
Int J Cardiol; 1990 Jul; 28 Suppl 1():S1-2. PubMed ID: 2145232
[TBL] [Abstract][Full Text] [Related]
20. The electrophysiologic effects of enoximone in patients with preexisting ventricular tachyarrhythmias.
Miles WM; Heger JJ; Minardo JD; Klein LS; Prystowsky EN; Zipes DP
Am Heart J; 1989 Jan; 117(1):112-21. PubMed ID: 2521415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
